Patent SG-11201808704Y-A (SG)
Title: Viral vector stabilization
Inventor: HASSINEN MINNA
IPC: A61K47/26
Filed: 2017-04-03
Abstract: INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property 11111 11111111 1 1111 11111 11111 111 11111 1 11 1111111111 1111111111111111 1111 1111111 Organization International Bureau (10) International Publication Number (43) International Publication Date .....0\"\"\"1 WO 2017/180344 A3 19 October 2017 (19.10.2017) WIPO I PCT (51) International Patent Classification: A61K 47/26 (2006.01) A61K 9/19 (2006.01) Declarations under Rule 4.17: A61K 35/76 (2015.01) — as to the identity of the inventor (Rule 4.170) — as to applicant's entitlement to apply for and be granted a (21) International Application Number: patent (Rule 4.17(0 PCT/US2017/025727 — as to the applicant's entitlement to claim the priority of the (22) International Filing Date: earlier application (Rule 4.17(iii)) — 03 April 2017 (03.04.2017) of inventorship (Rule 4.17(iv)) (25) Filing Language: English Published: — with international search report (Art. 21(3)) (26) Publication Language: English — before the expiration of the time limit for amending the claims and to be republished in the event of receipt of (30) Priority Data: 62/322,452 14 April 2016 (14.04.2016) US amendments (Rule 48.2(h)) (71) Applicant: TRIZELL LTD. [GB/GB]; Sanderum House (88) Date of publication of the international search report: Oakley Road, Chinnor, Oxfordshire OX39 4TW (GB). 17 May 2018 (17.05.2018) (71) Applicant (for US only): PHARMACEUTICAL PATENT ATTORNEYS, LLC [US/US]; 55 Madison Av- enue, 4th Floor, Morristown, NJ 07960-7397 (US). Inventors: HASSINEN, Minna; Microkatu 1S, 70210 (72) = = Kuopio (FI). PARKER, Nigel; Sanderum House Oakley Road, Chinnor, Oxfordshire OX39 4TW (GB). SHAW, _ = Robert; Sanderum House Oakley Road, Chinnor, Oxford- shire OX39 4TW (GB). Common Representative: PHARMACEUTICAL — (74) = PATENT ATTORNEYS, LLC; 55 Madison Avenue, 4th Floor, Morristown, NJ 07960-7397 (US). Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, (81) = DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, —= = = — _ = SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, = TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. = Designated States (unless otherwise indicated, for every (84) — = — kind of regional protection available): ARIPO (BW, GH, = GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). _ M 71' 71' M 0 GC 1-1 IN 1-1 (54) Title: VIRAL VECTOR STABILIZATION 0 ei (57) : Combining viral vector with surfactant preserves vector infectivity, and surfactant provided an unexpected benefit by 0 protecting viral vector from damage due to transient elevated temperature.